Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Autor: Weitz, Jeffrey I., Lensing, Anthonie W.A., Prins, Martin H., Bauersachs, Rupert, Beyer-Westendorf, Jan, Bounameaux, Henri, Brighton, Timothy A., Cohen, Alexander T., Davidson, Bruce L., Decousus, Hervé, Freitas, Maria C.S., Holberg, Gerlind, Kakkar, Ajay K., Haskell, Lloyd, Van Bellen, Bonno, Pap, Akos F., Berkowitz, Scott D., Verhamme, Peter, Wells, Philip S., Prandoni, Paolo, Riera Mestre, Antoni, EINSTEIN CHOICE Investigators

Publikováno v: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2017, 376 (13), pp.1211-1222
New England journal of medicine, 376(13), 1211-1222. Massachussetts Medical Society
New England Journal of Medicine, 376(13), 1211-1222. MASSACHUSETTS MEDICAL SOCIETY
Weitz, J I, Lensing, A W A, Prins, M H, Bauersachs, R, Beyer-Westendorf, J, Bounameaux, H, Brighton, T A, Cohen, A T, Davidson, B L, Decousus, H, Freitas, M C S, Holberg, G, Kakkar, A K, Haskell, L, Van Bellen, B, Pap, A F, Berkowitz, S D, Verhamme, P & Wells, P S & Prandoni, P 2017, ' Rivaroxaban or aspirin for extended treatment of venous thromboembolism ', New England Journal of Medicine, vol. 376, no. 13, pp. 1211-1222 . https://doi.org/10.1056/NEJMoa1700518
Dipòsit Digital de la UB
Universidad de Barcelona
New England Journal of Medicine, Vol. 376, No 13 (2017) pp. 1211-1222
The New England journal of medicine, vol. 376, no. 13, pp. 1211-1222
BASE-Bielefeld Academic Search Engine

Background: although many patients with venous thromboembolism require extended treatment, it is uncertain whether it is better to use full- or lower-intensity anticoagulation therapy or aspirin. Methods: in this randomized, double-blind, phase 3 stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1303896c40d103a54e012642942999
https://hal.univ-brest.fr/hal-02051875